Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-27

Clinical Trial Update: A Study to Evaluate Ketamine for the Treatment of Rett Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ketamine for Rett syndrome has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Rett Syndrome Research Trust | Conditions: Rett Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-03-27